Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetrorelix for Ovarian Function Preservation in Chemotherapy
NCT00507780Phase 4Withdrawn
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Jul 2007
- Primary completion
- Jul 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cetrorelix in primary ovarian insufficiency (POI), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Planned start Jul 2007; status: withdrawn.
02
Drugs
cetrorelix
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT00507780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00507780.